GAME CHANGER!! Zydus Unveils ANVIMO - A Revolutionary Drug for Transplant Patients Business Zydus Lifesciences has introduced a groundbreaking medication, ANVIMO, designed to prevent infections in patients undergoing bone marrow transplants and kidney transplants.